ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 19 filers reported holding ACHILLES THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $270,042 | +5.5% | 282,028 | -0.8% | 0.00% | 0.0% |
| Q4 2022 | $255,990 | -80.2% | 284,433 | -50.2% | 0.00% | -66.7% |
| Q3 2022 | $1,292,035 | -9.6% | 571,712 | +0.8% | 0.00% | 0.0% |
| Q2 2022 | $1,429,811 | -14.0% | 567,310 | +0.3% | 0.00% | +50.0% |
| Q1 2022 | $1,663,508 | +17.4% | 565,652 | +100.0% | 0.00% | -50.0% |
| Q4 2021 | $1,417,000 | -34.9% | 282,823 | +1.2% | 0.00% | -33.3% |
| Q3 2021 | $2,177,000 | -58.7% | 279,454 | -48.1% | 0.01% | -25.0% |
| Q2 2021 | $5,270,000 | – | 538,270 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 11,086,909 | $55,545,000 | 53.06% |
| RA Capital Management | 5,014,687 | $25,124,000 | 0.44% |
| Artal Group S.A. | 2,255,375 | $11,299,000 | 0.31% |
| Redmile Group, LLC | 2,088,089 | $10,461,000 | 0.24% |
| Orbimed Advisors | 1,584,845 | $7,940,000 | 0.10% |
| Sender Co & Partners, Inc. | 27,690 | $139,000 | 0.07% |
| Baker Brothers Advisors | 2,591,366 | $12,983,000 | 0.06% |
| Perceptive Advisors | 1,510,750 | $7,568,000 | 0.06% |
| Woodline Partners LP | 324,387 | $1,625,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,000,000 | $5,010,000 | 0.02% |